Guideline Resources
Consensus Guidelines for COVID-19 Drug Therapies
Key Points
To date, only remdesivir is FDA-approved for tx of COVID-19. Organizations that have published guidelines on COVID-19 management include NIH, WHO, IDSA (Infect Dis Soc Amer), SCCM (Soc Crit Care Med), ATS (Amer Thoracic Soc), PIDS (Pediatric ID Soc). Refer to source guidelines for methodology and evidence grades. See full table of recommendations by drug and NIH management recommendations for nonhospitalized and hospitalized adults.

Access published trial summaries and links to ongoing studies in epocrates’ COVID-19 Drug & Vaccine Trial Updates tool.
Choose Patient Type
Based on multiple guidelines/recommendations from specialty societies/government agencies.
Epocrates Guideline Synopsis Last Update: Oct 21, 2021
Publication Year:
ATS American Thoracic Society
CMA Canadian Medical Association
IDSA Infectious Diseases Society of America
NIH National Institutes of Health
PIDS Pediatric Infectious Diseases Society
SCCM Society of Critical Care Medicine
WHO World Health Organization